INTERLEUKIN LEVELS IN THE PATHOGENESIS OF CORONAVIRUS  INFECTION (COVID-19) AND THE EFFECT OF A NEW COMBINATION DRUG (G.  LUCIDUM AND ALKHADAYA) ON THE COURSE AND PROGNOSIS OF THE  DISEASE

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/3734

Title:	INTERLEUKIN LEVELS IN THE PATHOGENESIS OF CORONAVIRUS INFECTION (COVID-19) AND THE EFFECT OF A NEW COMBINATION DRUG (G. LUCIDUM AND ALKHADAYA) ON THE COURSE AND PROGNOSIS OF THE DISEASE
Authors:	Abilov P.M., Makhkamova F.T.
Issue Date:	2025
Publisher:	O'zbekiston, Toshkent ( Stomatologiya ) jurnal
Series/Report no.:	UDC;616.994.41-006.6-018.1:616.19-002
Abstract:	An outbreak of acute community acquired atypical pneumonia of unknown etiology was reported in Wuhan, the capital of Hubei Province in central China, in December 2019. The pathogen, which turned out to be a new coronavirus, had not previously been detected in human papillomaviruses and was named SARS CoV-2. On March 11, 2020, the WHO recognized the NCI epidemic as a pandemic. SARS-CoV-2 belongs to the genus Betacoronavirus family Coronaviridae .
URI:	http://repo.tma.uz/xmlui/handle/1/3734
Appears in Collections:

Files in This Item:

File	Description	Size	Format
10_INTERLEUKIN_LEVELS_IN_THE_PATHOGENESIS_OF_CORONAVIRUS_INFECTION.pdf		480.63 kB	Adobe PDF	View/Open

DSpace JSPUI